Phyto-N — FDA meeting
October 2026
The Company plans to hold a pre-IND meeting with the FDA in October 2026.Source filing
CURX biotech catalysts & pipeline
CURANEX PHARMACEUTICALS INC · Data as of 2026-09-08
Upcoming catalysts
Phyto-N — IND submission
Q4 2026
We are planning to submit an IND for the treatment of ulcerative colitis in the fourth quarter of 2026.Source filing